All Blogs

Apr 20, 2020

Research says copper disintegrates novel coronavirus – SARS-CoV-2- the moment it lands on the metal. The global coronavirus pandemic has made everyone around cautious of hygiene and cleanliness. The transmission of microbes through droplets, touching, sneezing has brought a wave face masks, 20-seconds hand wash,...

Apr 17, 2020

As per DelveInsight, the CAR T-Cell Therapy Market size for Non-Hodgkin lymphoma in the 6MM (the US, EU5 (the UK, Germany, France, Italy and Spain)) is expected to be USD 2796.2 Million by 2030. During the course of past decades, with the advancement in technology and a clear understanding of the molecular patho...

Apr 16, 2020

Vir's Hepatitis B drug shows positive results in phase 2 The hepatitis B drug of Vir Biotechnology has shown promising results. Its gene-silencing drug trim levels of the hepatitis B surface antigen in a small phase 2 study in patients who are already taking antiretroviral drugs. The drug, VIR-2218,...

Apr 15, 2020

The Novel Coronavirus since its outbreak in Wuhan China in November-2019 has infected around 1,848,439 people with 117,217 confirmed deaths in 213 countries, till date.  Countries around the world are working tirelessly to tackle the current situation. Local Governments in order to reduce the pace of corona...

Apr 14, 2020

Eli Lilly has announced to begin clinical trials of rheumatoid arthritis drug Olumiant to treat COVID-19 patients.  The company plans to explore the anti-inflammatory responses that were witnessed in rheumatoid arthritis patients, and how the drug – Olumiant – an oral JAK1/JAK2 inhibitor – might help in cur...

Apr 13, 2020

Amid the political debate, the US NIH has last week begun the clinical trials of the malarial drug hydroxychloroquine to test its efficacy and safety in patients with COVID-19. What is hydroxychloroquine?  Hydroxychloroquine (HCQ) (aka hydroxychloroquine sulfate), is a drug available in the market to tre...

Apr 10, 2020

DelveInsight estimates by 2030, the Car-T cell therapy market in Acute lymphoblastic leukaemia would approximate to USD 1,315.7 million in the 6MM (U.S. and EU5 including UK, Germany, Italy, France and Spain), emerging as a multi-billion-dollar industry. Acute lymphocytic leukemia (ALL) is a tumor that afflic...

Apr 09, 2020

AstraZeneca aims for summer start for COVID-19 antibody trial AstraZeneca has made its multipronged approach to the development of antibodies against the pandemic SARS-CoV-2 virus. The giant is utilizing its discovery capabilities and assisting in assessing the candidates who were identified in China and the U.S...

Apr 08, 2020

The novel coronavirus (COVID-19) within a span of five months, has infected around 1 million people, resulting in deaths of 50,000 people in over 180 countries around the world till date.  The major issue right now is containing its rapid transmission and effective treatment option. Apart from these issues,...

Apr 07, 2020

World Health Day Today, 7 April, is World Health Day. While the world is waging war against COVID-19, let us take a moment to be grateful to the emergency stuff- Doctors, Heath workers, Nurses who are taking care of the patients all day and night during this Coronavirus pandemic crisis.  Everyone is mainta...